Photocure (Norway) Management Evaluation
| PHO Stock | NOK 54.30 0.80 1.50% |
Photocure employs about 97 people. The company is managed by 8 executives with a total tenure of roughly 14 years, averaging almost 1.0 years of service per executive, having 12.13 employees per reported executive. Inspection of Photocure's management performance can provide insight into the company performance.
| Daniel Schneider CEO President CEO |
Photocure |
Photocure Management Team Effectiveness
The company has return on total asset (ROA) of (0.0309) % which means that it has lost $0.0309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1567) %, meaning that it generated substantial loss on money invested by shareholders. Photocure's management efficiency ratios could be used to measure how well Photocure manages its routine affairs as well as how well it operates its assets and liabilities.Photocure Workforce Comparison
Photocure is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 594. Photocure retains roughly 97.0 in number of employees claiming about 16% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1. Photocure Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Photocure Price Series Summation is a cross summation of Photocure price series and its benchmark/peer.
Photocure Notable Stakeholders
A Photocure stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Photocure often face trade-offs trying to please all of them. Photocure's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Photocure's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Daniel Schneider | President CEO | Profile | |
| Tolv Hillestad | Group Controller | Profile | |
| Erik Dahl | Chief Officer | Profile | |
| Patricia Kelly | VP HR | Profile | |
| David Moskowitz | Head Relations | Profile | |
| Anders Neijber | Clinical Affairs | Profile | |
| Kari MD | Head Devel | Profile | |
| Geoffrey Coy | VP Operations | Profile |
About Photocure Management Performance
The success or failure of an entity such as Photocure often depends on how effective the management is. Photocure management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Photocure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Photocure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people.
Photocure Workforce Analysis
Traditionally, organizations such as Photocure use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Photocure within its industry.Photocure Manpower Efficiency
Return on Photocure Manpower
| Revenue Per Employee | 3.7M | |
| Revenue Per Executive | 45.1M | |
| Net Loss Per Employee | 318.5K | |
| Net Loss Per Executive | 3.9M | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 20.4M |
Other Information on Investing in Photocure Stock
Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.